We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$68.8B
$21.8M 4.51%
69,640
-850
-1% -$224K
CELG
2
DELISTED
Celgene Corp
CELG
$20.7M 4.29%
268,940
-1,900
-0.7% -$133K
AMGN icon
3
Amgen
AMGN
$203B
$13.8M 2.85%
123,229
-1,560
-1% -$169K
LUV icon
4
Southwest Airlines
LUV
$22.1B
$13.2M 2.73%
905,507
+225
+0% +$3.06K
AAPL icon
5
Apple
AAPL
$4.89T
$12M 2.49%
707,308
+2,240
+0.3% +$37.1K
JPM icon
6
JPMorgan Chase
JPM
$939B
$10.8M 2.23%
208,692
-1,296
-0.6% -$69.5K
GE icon
7
GE Aerospace
GE
$367B
$9.71M 2.01%
84,763
+1,511
+2% +$173K
CL icon
8
Colgate-Palmolive
CL
$72.6B
$9.24M 1.91%
155,877
-2,100
-1% -$124K
PEP icon
9
PepsiCo
PEP
$186B
$8.77M 1.81%
110,341
-200
-0.2% -$16.4K
JNJ icon
10
Johnson & Johnson
JNJ
$635B
$8.41M 1.74%
96,968
-200
-0.2% -$17.9K
WMT icon
11
Walmart Inc
WMT
$871B
$8.1M 1.68%
328,719
-3,477
-1% -$87.7K
HON icon
12
Honeywell
HON
$77.1B
$7.55M 1.56%
101,201
-1,669
-2% -$124K
IBM icon
13
IBM
IBM
$202B
$7.39M 1.53%
41,721
-547
-1% -$99.4K
PG icon
14
Procter & Gamble
PG
$343B
$7.31M 1.51%
96,751
-150
-0.2% -$11.9K
KO icon
15
Coca-Cola
KO
$354B
$6.59M 1.36%
174,062
+4,351
+3% +$172K
V icon
16
Visa
V
$677B
$6.58M 1.36%
137,760
-1,000
-0.7% -$46.2K
SNDK
17
DELISTED
SANDISK CORP
SNDK
$6.17M 1.28%
103,712
-48
-0% -$2.82K
XOM icon
18
ExxonMobil
XOM
$651B
$6.12M 1.27%
71,153
-721
-1% -$65K
PM icon
19
Philip Morris
PM
$301B
$6.12M 1.27%
70,687
+50
+0.1% +$4.37K
BMY icon
20
Bristol-Myers Squibb
BMY
$127B
$6.07M 1.26%
131,131
-500
-0.4% -$21.9K
DD
21
DELISTED
Du Pont De Nemours E I
DD
$5.9M 1.22%
106,168
+1,382
+1% +$75.5K
BAC icon
22
Bank of America
BAC
$435B
$5.55M 1.15%
401,950
+8,346
+2% +$119K
INTC icon
23
Intel
INTC
$466B
$5.54M 1.15%
241,710
+1,945
+0.8% +$44.8K
EPD icon
24
Enterprise Products Partners
EPD
$83.8B
$5.28M 1.09%
173,100
-1,416
-0.8% -$43.3K
C icon
25
Citigroup
C
$222B
$5.08M 1.05%
104,654
+695
+0.7% +$35.1K
1
2 3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.